PEOPLE - Genelabs Technologies (US) makes appointment:
This article was originally published in Clinica
Executive Summary
Genelabs Technologies (US) has appointed Dr Irene Chow to the newly-created role of president and COO, with responsibility for strategic and operational activities relating to the company's worldwide diagnostic and biopharmaceutical businesses. Dr Chow was formerly president of Genelabs' biopharmaceutical division.